{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:52:26Z","timestamp":1789685546597,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijrobp.2021.02.049","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T18:28:15Z","timestamp":1614968895000},"page":"1496-1504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy"],"prefix":"10.1016","volume":"110","author":[{"given":"Andrew J.","family":"Bishop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt S.","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac D.","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody A.","family":"Wages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Fran","family":"McAleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold C.","family":"Paulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Grosshans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina D.","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Brandon","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.02.049_bib1","first-page":"551","article-title":"Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors","volume":"29","author":"Keegan","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib2","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/cncr.30562","article-title":"Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers","volume":"123","author":"Alvarez","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27738","article-title":"Trends in cancer incidence in US adolescents and young adults, 1973-2015","volume":"3","author":"Scott","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/cncr.22102","article-title":"Adolescents and young adults with cancer: The scope of the problem and criticality of clinical trials","volume":"107","author":"Bleyer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib5","first-page":"485","article-title":"Adolescent and young adult oncology\u2014past, present, and future","volume":"69","author":"Close","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz031","article-title":"Emerging cancer survival trends, disparities, and priorities in adolescents and young adults: A California Cancer Registry-based study","volume":"3","author":"Moke","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2017.08.020","article-title":"Identification of patients with localized Ewing sarcoma at higher risk for local failure: A report from the Children\u2019s Oncology Group","volume":"99","author":"Ahmed","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/PPO.0b013e3181b6d4b7","article-title":"Proton beam therapy in pediatric oncology","volume":"15","author":"Merchant","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2018.05.020","article-title":"Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN","volume":"128","author":"Weber","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib10","article-title":"Insurance coverage decisions for pediatric proton therapy","volume":"65","author":"Ojerholm","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: A systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ctrv.2015.12.007","article-title":"Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy","volume":"43","author":"Doyen","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib13","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1088\/0031-9155\/60\/8\/R155","article-title":"The physics of proton therapy","volume":"60","author":"Newhauser","year":"2015","journal-title":"Phys Med Biol"},{"issue":"Suppl 3","key":"10.1016\/j.ijrobp.2021.02.049_bib14","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1542\/peds.2014-0122D","article-title":"Understanding and addressing the lack of clinical trial enrollment among adolescents with cancer","volume":"133","author":"Tai","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib15","unstructured":"Cigna Medical Coverage Policies \u2013 Radiation Oncology. Evicore Healthcare.https:\/\/www.evicore.com\/-\/media\/files\/evicore\/provider\/network-standard\/cigna---radiation-therapy_v102019_eff01172019_pub10192018.pdf. Accessed March 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.02.049_bib16","unstructured":"United Healthcare Proton Beam Radiation Therapy. United Healthcare. https:\/\/www.uhcprovider.com\/content\/dam\/provider\/docs\/public\/policies\/signaturevalue-mmg\/proton-beam-radiation-therapy-sv.pdfAccessed March 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.02.049_bib17","unstructured":"Anthem Radiation Oncology: Proton Beam Therapy Clinical Appropriateness Guideline. Anthem. https:\/\/anthempc-attachments-prod.s3.us-west-2.amazonaws.com\/pdf\/articles\/Updates%20to%20AIM%20Radiation%20Oncol...%20-%20oh2857.pdfAccessed March 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.02.049_bib18","unstructured":"Aetna: Proton Beam, Neutron Beam, and Carbon Ion Radiotherapy, Aetna. http:\/\/www.aetna.com\/cpb\/medical\/data\/200_299\/0270.htmlAccessed March 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.02.049_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djz039","article-title":"Impact of health insurance on stage at cancer diagnosis among adolescents and young adults","volume":"111","author":"Keegan","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2018.12.021","article-title":"Insurance approval for proton beam therapy and its impact on delays in treatment","volume":"104","author":"Gupta","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib21","unstructured":"Cancer care denied: The broken state of patient acccess to proton therapy, Alliance for Proton Therapy Access. http:\/\/allianceforprotontherapy.org\/wp-content\/uploads\/2018\/05\/Cancer-Care-Denied-Report.pdf. Accessed March 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.02.049_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2018.10.022","article-title":"Patterns of proton therapy use in pediatric cancer management in 2016: An international survey","volume":"132","author":"Journy","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.19.01706","article-title":"Superior intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma","volume":"38","author":"Kahalley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/pbc.22164","article-title":"Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children\u2019s Oncology Group","volume":"53","author":"Bleyer","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib25","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's Lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2013.01.014","article-title":"Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma","volume":"86","author":"Brown","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.04.027","article-title":"Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma","volume":"137","author":"Tabrizi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib29","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1523\/JNEUROSCI.5302-10.2011","article-title":"Longitudinal development of human brain wiring continues from childhood into adulthood","volume":"31","author":"Lebel","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib30","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1200\/JCO.2017.76.3839","article-title":"Improving male reproductive health after childhood, adolescent, and young adult cancer: Progress and future directions for survivorship research","volume":"36","author":"Kenney","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/jayao.2013.0038","article-title":"Preserving fertility in adolescent girls and young women requiring craniospinal irradiation: A case report and discussion of options to be considered prior to treatment","volume":"3","author":"Lester-Coll","year":"2014","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijrobp.2020.07.2320","article-title":"Proton radiotherapy to preserve fertility and endocrine function: A translational investigation","volume":"109","author":"Gross","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamapediatrics.2015.4689","article-title":"Cancer in adolescents and young adults: A narrative review of the current status and a view of the future","volume":"170","author":"Barr","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","article-title":"Incidence of second malignancies among patients treated with proton versus photon radiation","volume":"87","author":"Chung","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib35","unstructured":"Bluecross Blueshield of Texas: Charged-Particle Radiation Therapy, BlueCross BlueShield. https:\/\/www.bcbstx.com\/provider\/pdf\/medicalpolicies\/therapy\/801-023ps.pdfAccessed March 12, 2020."},{"key":"10.1016\/j.ijrobp.2021.02.049_bib36","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jamaoto.2017.3406","article-title":"Association of survival with shorter time to radiation therapy after surgery for us patients with head and neck cancer","volume":"144","author":"Harris","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1200\/JCO.2003.04.171","article-title":"Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review","volume":"21","author":"Huang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-007-9426-z","article-title":"Delay in radiotherapy shortens survival in patients with high grade glioma","volume":"85","author":"Irwin","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.02.049_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13014-019-1272-6","article-title":"Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma","volume":"14","author":"Katsigiannis","year":"2019","journal-title":"Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621002340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621002340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:54:04Z","timestamp":1759744444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621002340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0360301621002340"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.02.049","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}